0001288123-18-000018.txt : 20180622 0001288123-18-000018.hdr.sgml : 20180622 20180622165832 ACCESSION NUMBER: 0001288123-18-000018 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180621 FILED AS OF DATE: 20180622 DATE AS OF CHANGE: 20180622 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cortis Christian CENTRAL INDEX KEY: 0001744495 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-29089 FILM NUMBER: 18915133 MAIL ADDRESS: STREET 1: 3 FORBES ROAD CITY: LEXINGTON STATE: MA ZIP: 02421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AGENUS INC CENTRAL INDEX KEY: 0001098972 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 061562417 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3 FORBES ROAD CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-674-4410 MAIL ADDRESS: STREET 1: 3 FORBES ROAD CITY: LEXINGTON STATE: MA ZIP: 02421 FORMER COMPANY: FORMER CONFORMED NAME: ANTIGENICS INC /DE/ DATE OF NAME CHANGE: 19991115 3 1 primary_doc.xml PRIMARY DOCUMENT X0206 3 2018-06-21 0 0001098972 AGENUS INC AGEN 0001744495 Cortis Christian 3 FORBES ROAD LEXINGTON MA 02421 0 1 0 0 Chief Strategy Officer Common Stock 19849 D Stock Option, right to buy 6.85 2016-04-13 2025-05-01 Common Stock 85000 D Stock Option, right to buy 4.16 2017-03-31 2026-03-31 Common Stock 50000 D Stock Option, right to buy 3.77 2018-03-31 2027-03-31 Common Stock 60000 D Stock Option, right to buy 5.65 2019-03-02 2028-03-02 Common Stock 100000 D Options awarded in accordance with the Agenus Inc. Amended and Restated 2009 Equity Incentive Plan and vests in four equal annual installments beginning April 13, 2016. Options awarded in accordance with the Agenus Inc. Amended and Restated 2009 Equity Plan and vests in three years with one-third vested on March 31, 2017 and the balance in equal quarterly installments. Option awarded in accordance with the Agenus Inc. Amended and Restated 2009 Equity Incentive Plan and vests on-third on the one-year anniversary of the grant date, March 31, 2017, with the balance vesting in equal quarterly installments thereafter. Options was granted on March 2, 2018 subject to shareholder approval, which was obtained at the Company's annual shareholder meeting on June 20, 2018. Option awarded in accordance with the Agenus Inc. Amended and Restated 2009 Equity Incentive Plan, and vests over three years with one-third of the award vesting on March 2, 2019 and the balance vesting in equal quarterly installments thereafter. Christine M. Klaskin, by Power of Attorney 2018-06-22